Delayed interval of involvement of the second eye in a male patient with bilateral Chandler's syndrome

Another study reported 28 patients with subclinical endothelial abnormalities, including increased variation of cell area and decreased percentage of hexagonal cells compared with normal controls. 10 The presence of endothelial abnormalities in the asymptomatic eyes of patient's with ICE raises...

Full description

Saved in:
Bibliographic Details
Published inBritish journal of ophthalmology Vol. 96; no. 1; pp. 134 - 135
Main Authors Lobo, A-M, Rhee, D J
Format Journal Article
LanguageEnglish
Published BMA House, Tavistock Square, London, WC1H 9JR BMJ Publishing Group Ltd 01.01.2012
BMJ Publishing Group
BMJ Publishing Group LTD
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Another study reported 28 patients with subclinical endothelial abnormalities, including increased variation of cell area and decreased percentage of hexagonal cells compared with normal controls. 10 The presence of endothelial abnormalities in the asymptomatic eyes of patient's with ICE raises the question as to whether this can truly be called a unilateral disease process. Chandler originally described a syndrome where abnormalities of the posterior aspect of the cornea were present with minimal iris atrophy and no hole formation. 1 13 The pathogenesis of ICE syndrome is related to abnormal endothelial cells which create a membrane that grows over the angle structures and causes atrophy of the iris. 1 With regard to the histopathologic findings from the enucleated eye, the endothelial cell count and corneal stromal oedema could have been further compromised from the multiple prior glaucoma surgeries including two trabeculectomies and glaucoma drainage device as this consequence has been documented by other investigators. 14 If there are endothelial abnormalities in both eyes, it is unknown why the endothelial changes in one eye are confined to the subclinical level.
Bibliography:PMID:20710048
ark:/67375/NVC-JC9N9H8C-8
local:bjophthalmol;96/1/134
href:bjophthalmol-96-134.pdf
ArticleID:bjophthalmol177931
istex:1386EAF8A848F9DA57C02CC6DD371B7B72B71D54
ObjectType-Case Study-2
SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
ISSN:0007-1161
1468-2079
DOI:10.1136/bjo.2009.177931